RxDoctor Payments Data

Carrie Meyer

Physician Assistant · Littleton, CONPI 1720065956

Payments from drug & device makers

$641in general payments, 2019–2025

Across 23 payments — averaging $27.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$118
  • Tandem Diabetes Care, Inc.$107
  • Novo Nordisk$75
  • Corcept Therapeutics$68
  • Lilly USA, LLC$65
  • Medtronic$58
  • plus $151 from 4 others

What the payments were for

  • Food & beverage$641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$641 in reported general payments places this provider in the 70th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$48,688
Medicare patients
88
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide320$459,101
TrulicityDulaglutide154$245,467
JardianceEmpagliflozin132$171,788
OzempicSemaglutide105$132,456
RybelsusSemaglutide74$127,816
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/724$44,162
FarxigaDapagliflozin Propanediol18$25,486
Lantus SolostarInsulin Glargine,hum.Rec.Anlog129$16,200
Tresiba Flextouch U-100Insulin Degludec27$15,192
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt14$14,787
JanuviaSitagliptin Phosphate16$11,809
Humalog Kwikpen U-100Insulin Lispro58$11,394
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$11,161
Fiasp FlextouchInsulin Aspart (Niacinamide)14$10,214
Insulin Lispro Kwikpen U-100Insulin Lispro30$5,427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$65$711,133509 claims
Novo NordiskOzempic, Rybelsus, Novolog$75$261,600193 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →